in addition to the immunosuppressive therapy , most patients received additional conventional medications for heart failure between evaluation periods ( mean number of cardiac drugs increased from 1.7 +/- 1.0 to 2.7 +/- 0.05 , p = 0.041 ) .
C0018801
heart failure
C0018787
cardiac